595 related articles for article (PubMed ID: 2161532)
1. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
Falk RJ; Terrell RS; Charles LA; Jennette JC
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4115-9. PubMed ID: 2161532
[TBL] [Abstract][Full Text] [Related]
2. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
Franssen CF; Huitema MG; Muller Kobold AC; Oost-Kort WW; Limburg PC; Tiebosch A; Stegeman CA; Kallenberg CG; Tervaert JW
J Am Soc Nephrol; 1999 Jul; 10(7):1506-15. PubMed ID: 10405206
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.
Jennette JC; Wilkman AS; Falk RJ
Am J Pathol; 1989 Nov; 135(5):921-30. PubMed ID: 2683800
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.
Jennette JC; Falk RJ
Am J Kidney Dis; 1990 Jun; 15(6):517-29. PubMed ID: 1973331
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.
Gross WL; Csernok E; Schmitt WH
Klin Wochenschr; 1991 Sep; 69(13):558-66. PubMed ID: 1721666
[TBL] [Abstract][Full Text] [Related]
7. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
8. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA).
Falk RJ; Hogan SL; Wilkman AS; Terrell RS; Lauritzen S; Charles LA; Jennette JC
Neth J Med; 1990 Apr; 36(3-4):121-5. PubMed ID: 2162486
[No Abstract] [Full Text] [Related]
10. [Anti-neutrophil cytoplasmic autoantibody (ANCA) in systemic vasculitic syndrome].
Arimura Y; Nagasawa T
Rinsho Byori; 1993 Aug; 41(8):866-75. PubMed ID: 8371502
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells.
Charles LA; Falk RJ; Jennette JC
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):243-53. PubMed ID: 2551551
[TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
14. [Anti-cytoplasm antibodies to polynuclear neutrophils: specificity in renal vasculitis].
Soler C; Dupré-Goudable C; Rey JP; Modesto A; Oksman F; Suc JM
Ann Biol Clin (Paris); 1993; 51(2):133-9. PubMed ID: 8214812
[TBL] [Abstract][Full Text] [Related]
15. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
Wüthrich RP
Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270
[TBL] [Abstract][Full Text] [Related]
16. [Anti-neutrophil cytoplasmic antibodies ANCA in glomerulonephritis and systemic vasculitis with renal involvement--the frequency of occurrence and ability for granulocyte activation in vitro].
Mazanowska O; Klinger M; Wendycz-Domalewska D; Kopeć W
Pol Arch Med Wewn; 1998 May; 99(5):390-7. PubMed ID: 9816888
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitides.
Macconi D; Zanoli AF; Orisio S; Longaretti L; Magrini L; Rota S; Radice A; Pozzi C; Remuzzi G
Kidney Int; 1993 Jul; 44(1):215-20. PubMed ID: 8394950
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.
Falk RJ; Hogan S; Carey TS; Jennette JC
Ann Intern Med; 1990 Nov; 113(9):656-63. PubMed ID: 2221646
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis.
Niles JL; Pan GL; Collins AB; Shannon T; Skates S; Fienberg R; Arnaout MA; McCluskey RT
J Am Soc Nephrol; 1991 Jul; 2(1):27-36. PubMed ID: 1655091
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
